Ocutrx Included in Next Big Things in Tech

Ocutrx Technologies has been recognized for its groundbreaking work in Next Big Things in Tech.

Image credits: Ocutrx

In a world where vision loss and impairment affect millions, Ocutrx Technologies, Inc., a pioneer in augmented reality (AR) and 3D technology, has been recognized for its groundbreaking work. Today, Ocutrx announces its inclusion in Fast Company's third annual Next Big Things in Tech list, a prestigious accolade that honors technology breakthroughs with the potential to shape the future of industries and improve lives.

At the heart of Ocutrx's recognition is its latest innovation, OcuLenz, an AR/XR headset engineered to enhance visual clarity for individuals living with advanced macular degeneration (AMD), the leading cause of vision loss in adults over 65. This innovative device represents a significant step forward in visual aid technology. User-friendly and lightweight, OcuLenz stands as a beacon of hope for those who need it most, employing advanced pixel manipulation to overlay high-contrast images onto the user's viable field of view.

"The Next Big Things in Tech is not just a look around the corner—it's a look around the corner after that," says Brendan Vaughan, editor-in-chief of Fast Company. "These are the products and ideas that will define technological innovation for the rest of this decade and beyond—and solve some of the world's most pressing issues. We are thrilled to honor the organizations that are making them a reality."

Adding to its capabilities, the OcuLenz headset is designed for both functionality and mobility. Users can freely move and perform everyday tasks while wearing it, benefiting from its high resolution of 2.5K per eye and an extensive field of view. This transformative tool shifts the focus from impaired central vision to more effective peripheral vision, enhancing users' overall experience.

"What an incredible honor," said Michael Freeman, co-founder, CEO and CTO of Ocutrx. "Developing the OcuLenz headset was directly inspired by our father, Gen. Richard Freeman's, diagnosis with Advanced Macular Degeneration. His condition and indomitable spirit were the catalysts for our invention. This personal endeavor has evolved with the hope of helping millions more face similar visual challenges. Receiving this award is not only a recognition of our technological innovation but also a validation of our mission to significantly improve the quality of life for those affected by visual impairments."

Related: Mojo Vision Unveils Augmented Reality Contact Lens Prototype

About Fast Company

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Brendan Vaughan. Fast Company is headquartered in New York City.

About OcuLenz

OcuLenz for AMD, Ocutrx Technologies' advanced AR headset, marks a major advancement in aiding those with advanced macular degeneration(AMD) and Stargardts (the juvenile form of AMD). This innovative device, rooted in personal experience and driven by compassion, is set to significantly enhance visual perception and quality of life for AMD sufferers. With its high-tech design utilizing pixel manipulation, high resolution, and a broad field of view, OcuLenz opens up a clearer, more vivid world, ensuring that the central vision loss characteristic of AMD no longer dictates the boundaries of a patient's world.

Pre-orders for the OcuLenz headset are now available on the Oculenz website.

About Ocutrx

Ocutrx Technologies, Inc., anchored in the US and Europe, he leads in AR/XR and 3D visualization, expanding its horizons across various industries. Founded by Michael and Mitch Freeman, two Emmy Award Winning Inventors of mobile video in the 1990s, the company emerged from a passion to tackle the adversities of Advanced Macular Degeneration.

Sam Draper
December 11, 2023

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Biofourmis Raises Another $20M from Intel Capital

Intel Capital joined Biofourmis' Series D financing in an extension. Total funding stands at $320M.

Mojo Vision Unveils Augmented Reality Contact Lens Prototype

Mojo Vision announced its most advanced prototype of Mojo Lens.

Nielsen to Start Placing PPM Wearables To Modernize and Improve Panelist Experience

Nielsen today announced that starting in September 2021, it will begin placing approximately ...

How Wearables Like Oura and Whoop Became Pandemic Lifestyle

During quarantine, obsessive health tracking has become a hobby for people with means. Adelene...
Discover more